Results 1 to 10 of about 5,948 (206)

Spectrum of Dystonia in Spinocerebellar Ataxia. [PDF]

Tremor Other Hyperkinet Mov (N Y)
Yellaturi SR, Mukherjee A, Pandey S.
europepmc   +1 more source

Rad23b exacerbates pathological aggregates through disrupting proteasome functions in Spinocerebellar ataxia type 3. [PDF]

Neurotherapeutics
Chen YC, Tung CW, Chan SC, Wu PM, Cheng PH, Chen CM, Yang SH.   +6 more
europepmc   +1 more source

The association between diplopia and clinical phenotypes in spinocerebellar ataxia type 3. [PDF]

BMC Neurol
Zheng M, Cui ML, Lin W, Huang ZY, Cai B, Gan SR.   +5 more
europepmc   +1 more source

Predictive models for ataxia progression and conversion in spinocerebellar ataxia type 1 and 3. [PDF]

Brain
Petit E, Coarelli G, Morgan D, Cunha P, Hurmic H, Faber J, Grobe-Einsler M, Rezende T, Kuo SH, Wilmot GR, Rosenthal LS, Schmahmann JD, Yacoubian TA, Perlman SL, Geschwind MD, Gomez CM, Hawkins T, Subramony SH, Shakkottai VG, Bushara KO, Zesiewicz TA, Pulst SM, Park YW, Lenglet C, Klockgether T, Paulson HL, Durr A, Öz G, Ashizawa T, Tezenas du Montcel S.   +29 more
europepmc   +1 more source

Relationship of subclinical lung injury to chronic airway inflammation in spinocerebellar ataxia type 3. [PDF]

Orphanet J Rare Dis
Lv XT, Lin W, Ye BN, Zhang ZW, Lin H, Zhang JY, Zhou ZY, Cui ML, Huang ZY, Wang N, Gan SR, OSCCAR Investigators.   +11 more
europepmc   +1 more source

Hypothalamic Atrophy and Textural Changes in Polyglutamine Ataxias. [PDF]

Cerebellum
Rodrigues L, Rezende TJR, Martinez ARM, Massuyama B, Pedroso JL, Barsottini OGP, Iglesias JE, Appenzeller S, Rittner L, França MC.   +9 more
europepmc   +1 more source

IGFBP1 as a metabolic-neurodegenerative biomarker in spinocerebellar ataxia type 3. [PDF]

Exp Ther Med
Chiu C, Cheng W, Lin T, Chang H, Chang Y, Su S, Lee C, Chang H, Liu C.   +8 more
europepmc   +1 more source

Pediatric-onset spinocerebellar ataxia type 3 with dual <i>ATXN3</i> and <i>HTT</i> gene mutations: a case report and literature-informed hypothesis. [PDF]

Front Genet
Wang D, Zhou M, Du K, Wang Y, Tang K, Duan Y, Shi M, Wu H.   +7 more
europepmc   +1 more source

Repurposing of natural products for spinocerebellar ataxia type 3 using integrated network pharmacology and in silico approaches. [PDF]

Sci Rep
Roney M, Mohd Hisam NS, Uddin MN, Istiaque Hamim SM, Lim LW, Wong KH.   +5 more
europepmc   +1 more source

Gastrodin inhibits the formation of ataxin-3 aggregates by regulating the level of ERK1/2/P38 proteins. [PDF]

Orphanet J Rare Dis
Wang Z, Xiao X, Wang M, Cheng R, Wang C, Liu Y, He F, Xie X.   +7 more
europepmc   +1 more source